User:Tkadm30/Notebook/Endocannabinoids: Difference between revisions
From OpenWetWare
< User:Tkadm30 | Notebook
(→Notes) |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 4: | Line 4: | ||
=== Hypothesis === | === Hypothesis === | ||
DHA | # DHA may potentiate synaptic plasticity (and cognition) via [http://www.nature.com/mp/journal/v7/n3/full/4000999a.html retrograde CB1 signaling]. | ||
=== Model === | === Model === | ||
# Use omega 3 (DHA) fatty acids as substrate for docosahexaenoylethanolamide (DHEA) hydrolysis | # Use omega 3 (DHA) fatty acids as substrate for docosahexaenoylethanolamide (DHEA) hydrolysis | ||
# Protect the hippocampus and neurons from stress induced damage. | # Protect the hippocampus and neurons from stress induced damage. | ||
# CB1: A synaptogenic receptor | |||
=== Documentation === | === Documentation === | ||
Protocol: | Protocol: | ||
Revision as of 12:40, 29 September 2014
Notes
Hypothesis
- DHA may potentiate synaptic plasticity (and cognition) via retrograde CB1 signaling.
Model
- Use omega 3 (DHA) fatty acids as substrate for docosahexaenoylethanolamide (DHEA) hydrolysis
- Protect the hippocampus and neurons from stress induced damage.
- CB1: A synaptogenic receptor
Documentation
Protocol:
- http://www.ncbi.nlm.nih.gov/pubmed/23103355
- http://www.ncbi.nlm.nih.gov/pubmed/11470906
- http://www.ncbi.nlm.nih.gov/pubmed/9842734/
- http://www.ncbi.nlm.nih.gov/pubmed/15111006/
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1253627/
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035504/
- http://www.ncbi.nlm.nih.gov/pubmed/22959887
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219532/
CB1 signaling and memory:
- http://www.ncbi.nlm.nih.gov/pubmed/24648181
- Cannabinoids and hippocampal neurogenesis:
DHA:
Anandamide signaling:
FAAH (fatty acid amide hydrolase):
Introduction to fatty amides:
Keywords
hippocampus, anandamide, FAAH, fatty acids, THC, neurogenesis, synaptogenesis
